Search research articles
Contact Us
Filters
Showing results (281-290 of 328) with videos related to
Page
of 33
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Chemoenzymatic syntheses of fluorine-18-labeled disaccharides from [
Alexandre M Sorlin, Marina López-Álvarez, Sarah J Rabbitt, et al.
Nucleic Acids Research
|
January 2, 2015
DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes
Peter Sykora, Magdalena Misiak, Yue Wang, et al.
Bioorganic & Medicinal Chemistry
|
July 30, 2010
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds
Dan Niculescu-Duvaz, Ion Niculescu-Duvaz, Bart M J M Suijkerbuijk, et al.
Advanced Healthcare Materials
|
May 3, 2024
Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer
Niranjan Meher, Gary W Ashley, Kondapa Naidu Bobba, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2012
Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)
Jonathan Seal, Yann Lamotte, Frédéric Donche, et al.
Journal of Medicinal Chemistry
|
December 7, 2007
4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists
Panayiotis A Procopiou, Rachael A Ancliff, Mark J Bamford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2015
A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer
Alex A Adjei, Donald A Richards, Anthony El-Khoueiry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2026
Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugates
Anil P Bidkar, Scott Bidlingmaier, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2025
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy
Anil P Bidkar, Robin Peter, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2023
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma
Anju Wadhwa, Sinan Wang, Bonell Patiño-Escobar, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 328) with videos related to
Sort By:
Page
of 33
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Chemoenzymatic syntheses of fluorine-18-labeled disaccharides from [
Alexandre M Sorlin, Marina López-Álvarez, Sarah J Rabbitt, et al.
Nucleic Acids Research
|
January 2, 2015
DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes
Peter Sykora, Magdalena Misiak, Yue Wang, et al.
Bioorganic & Medicinal Chemistry
|
July 30, 2010
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds
Dan Niculescu-Duvaz, Ion Niculescu-Duvaz, Bart M J M Suijkerbuijk, et al.
Advanced Healthcare Materials
|
May 3, 2024
Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer
Niranjan Meher, Gary W Ashley, Kondapa Naidu Bobba, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 23, 2012
Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)
Jonathan Seal, Yann Lamotte, Frédéric Donche, et al.
Journal of Medicinal Chemistry
|
December 7, 2007
4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists
Panayiotis A Procopiou, Rachael A Ancliff, Mark J Bamford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2015
A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer
Alex A Adjei, Donald A Richards, Anthony El-Khoueiry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2026
Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugates
Anil P Bidkar, Scott Bidlingmaier, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2025
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy
Anil P Bidkar, Robin Peter, Anju Wadhwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2023
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma
Anju Wadhwa, Sinan Wang, Bonell Patiño-Escobar, et al.
Page
of 33